Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
TNGX
#1518
Tango Therapeutics, Inc. - Common Stock
23.3
4
USD
-0.08%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-7.67%
Monthly Change
-11.46%
6 month change
+115.71%
Year Change
+253.10%
Previous Close
25.2
8
Open
23.3
4
Low
23.3
4
High
23.3
4
Volume
362
Markets
US Stock Market
Healthcare
Biotechnology
TNGX
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
21.38 M
87.71 M
88.2 M
106.72 M
108.11 M
142.69 M
168.61 M
Valuation ratios
Enterprise value
—
816.78 M
584.8 M
998.66 M
264.52 M
1.15 B
3.78 B
Price to earnings ratio
—
—
-5.94
-9.24
-2.6
-10.18
-28.82
Price to sales ratio
—
—
25.82
25.84
8.02
16.5
—
Price to cash flow ratio
—
—
5.89
8
2.57
-7.41
-22.54
Price to book ratio
—
—
2.57
3.73
1.69
2.97
1.76
Enterprise value to EBITDA ratio
—
-14.26
-5.34
-8.94
-1.85
-10.57
—
Profitability ratios
Return on assets %
—
-0.12
-0.25
-0.25
-0.41
-0.25
-0.05
Return on equity %
—
-0.17
-0.43
-0.4
-0.65
-0.29
0.05
Return on invested capital %
—
-222.9
-607.78
-467.22
-700.47
-808
419.15
Gross margin %
—
100
100
100
100
100
—
Operating margin %
—
-157.09
-446.79
-312.57
-346.09
-178.39
—
EBITDA margin %
—
-154.67
-440.32
-305.96
-340.15
-174.74
—
Net margin %
—
-157.21
-435.14
-278.54
-309.73
-162.85
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
13.1
12.1
6.76
7.54
6.98
16.32
50.82
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
—
0.11
0.05
0.09
0.12
0.17
0
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
-1.24
-1.25
-1.2
-1.2
-1.09
EBIT per share
—
—
-1.26
-1.21
-1.33
-0.96
-0.98
EBITDA per share
—
—
-1.25
-1.18
-1.31
-0.94
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
—
7.66
6.42
2.36
2.95
6.67
Net current asset value per share
—
—
4.27
3.66
2.44
3.05
6.88
Tangible book value per share
—
—
2.84
2.68
1.83
2.98
6.84
Working capital per share
—
—
3.64
3.18
2.09
2.86
6.75
Book value per share
—
—
2.84
2.68
1.83
2.98
6.84
News
RVMD Secures FDA Win, Gets Nod for Rasonque in Pancreatic Cancer
Tango Therapeutics Stock: Promising Early Data, But A Long Road Ahead (NASDAQ:TNGX)
TNGX Stock Dips 5% as Q2 Earnings Miss Estimates on Higher Expenses
4 Biotech Stocks Likely to Outpace Q2 Earnings Estimates
FDA Accepts RVMD's Filing for Daraxonrasib in Pancreatic Cancer
How Much Upside is Left in Tango Therapeutics (TNGX)? Wall Street Analysts Think 49.48%
Tango Therapeutics Rides a New Precision Oncology Trend in 2026
Is TNGX Stock Still Worth Buying After Its Huge Rally in 2026?
TNGX Stock Outlook Hinges on Vopimetostat and Key 2026 Catalysts
Biotech Is The Rate Cut Trade In Disguise
Tango Therapeutics: Combo Data With Revolution's RAS Inhibitor Whets Risk Appetite (TNGX)
TNGX Stock Jumps 53% on Early Pancreatic Cancer Study Results